ELYM - Eliem Therapeutics GAAP EPS of -$0.29 beats by $0.04
2023-03-06 17:32:22 ET
- Eliem Therapeutics press release ( NASDAQ: ELYM ): Q4 GAAP EPS of -$0.29 beats by $0.04 .
- Cash, cash equivalents and marketable securities were $123.6 million as of December 31, 2022, compared to $161.4 million as of December 31, 2021.
For further details see:
Eliem Therapeutics GAAP EPS of -$0.29 beats by $0.04